Potential Use of Interferon-α in Ophthalmological Disorders
- 3 November 1996
- journal article
- review article
- Published by Springer Nature in Clinical Immunotherapeutics
- Vol. 6 (5) , 383-394
- https://doi.org/10.1007/bf03259357
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alphaJournal of Hepatology, 1995
- Major Therapeutic Uses of InterferonsClinical Immunotherapeutics, 1995
- α-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markersJournal of Hepatology, 1993
- Intralesional interferon therapy for basal cell carcinomaJournal of the American Academy of Dermatology, 1990
- Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins.The Journal of Experimental Medicine, 1989
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Treatment of basal cell carcinoma with intralesional interferonJournal of the American Academy of Dermatology, 1986
- Phase II study of recombinant leukocyte a interferon (rIFN-αA) in disseminated malignant melanomaCancer, 1984
- Increased Levels of Interferon-induced (2′–5′) Oligo-Isoadenylate Synthetase in Mature T-Lymphocytes and in Differentiated Friend-Erythroleukemic CellsJournal of Interferon Research, 1981
- Inhibition of collagen cross-linking: A new approach to ocular scarringCurrent Eye Research, 1981